Japanese SPF sends message that it is more than just a patent assertion entity with new drug discovery collaboration
IP Bridge (IPB) – the company that operates Japan’s sovereign patent fund (SPF) – announced last week that it has signed a drug discovery deal with Kyushu University, indicating that it is aiming beyond straight monetisation activities to fulfil its…
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.